- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/02 - Immunomodulators
Patent holdings for IPC class A61P 37/02
Total number of patents in this class: 5370
10-year publication summary
|
192
|
182
|
283
|
420
|
396
|
551
|
544
|
561
|
468
|
206
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2713 |
43 |
| Daiichi Sankyo Company, Limited | 1869 |
38 |
| The Regents of the University of California | 19918 |
36 |
| Bristol-myers Squibb Company | 4898 |
29 |
| Ono Pharmaceutical Co., Ltd. | 434 |
29 |
| Osaka University | 3376 |
25 |
| Regeneron Pharmaceuticals, Inc. | 4264 |
25 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 644 |
25 |
| The University of Tokyo | 4176 |
25 |
| Dainippon Sumitomo Pharma Co., Ltd. | 194 |
24 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
24 |
| Taisho Pharmaceutical Co., Ltd. | 870 |
24 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
23 |
| F. Hoffmann-La Roche AG | 7925 |
22 |
| The Trustees of the University of Pennsylvania | 4322 |
21 |
| Chugai Seiyaku Kabushiki Kaisha | 1355 |
21 |
| Dana-Farber Cancer Institute, Inc. | 2571 |
21 |
| The Board of Trustees of the Leland Stanford Junior University | 6408 |
20 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
20 |
| The Brigham and Women's Hospital, Inc. | 2188 |
19 |
| Other owners | 4856 |